Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac Surgery

Stopped The study was terminated due to a considerably lower recruitment rate than anticipated

Conditions

• Cardiac Surgery
• Coronary Artery Bypass Grafting
• Valve Surgery
• Kidney Injury

Interventions

• DRUG: AP214
• DRUG: Placebo

Sponsor

Action Pharma A/S